Consensus Core Laboratories Inc.

Stocks

CLB

US21867A1051

Business Support Services

Market Closed - NYSE Other stock markets 00:00:02 13/06/2026 +04			5-day change	1st Jan Change
13.16 ^USD	-0.68%		+1.78%	-17.90%

04-30	Core Laboratories Inc., Q1 2026 Earnings Call, Apr 30, 2026
04-30	Earnings Flash (CLB) Core Laboratories Inc. Reports Q1 Revenue $121.8M, vs. FactSet Est of $123.0M	MT

Evolution of the Average Target: Core Laboratories Inc.

Evolution of the Target Price: Core Laboratories Inc.

Changes in Analyst Recommendations: Core Laboratories Inc.

4f3ef4765f1da3679a1d299dc7dade._UE8dHxuePfo8hpCqqUHMfFdLwJZbjjG2gSunfYJyHs.yhhJDS4tMKK9hGwX3shlCa4YRFcMP0vxtG-bxJ1GvTfKcwlEHlZKpN2cbQ~228cc64dd91c568b0127575782026569

Analysts' recommendations: Core Laboratories Inc.

12/03/25	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $16 From $15	MT
06/03/25	Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating	MT
25/10/24	The Zephirin Group Upgrades Core Laboratories to Buy from Hold; Adjusts Price Target to $22 from $18	MT
25/10/24	Zephirin Group Upgrades Core Laboratories to Buy Medium Risk From Hold Medium Risk, Raises Price Target to $22 From $18	MT
15/07/24	Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating	MT
29/01/24	Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating	MT
18/09/23	Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating	MT
31/07/23	Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating	MT
30/06/23	Citigroup Downgrades Core Laboratories to Sell From Neutral, Trims Price Target to $21 From $22	MT
01/05/23	Morningstar Upgrades Core Laboratories to Buy From Hold, $29 Price Target	MT
01/05/23	Piper Sandler Adjusts Core Laboratories' Price Target to $19 From $18, Keeps Neutral Rating	MT
28/04/23	Stifel Adjusts Core Laboratories' Price Target to $25 From $24, Keeps Hold Rating	MT
18/04/23	BofA Downgrades Core Laboratories to Underperform From Neutral, Price Target is $21.50	MT
07/02/23	Citigroup Adjusts Price Target on Core Laboratories N.V to $26 From $21, Maintains Neutral Rating	MT
09/01/23	BofA Securities Upgrades Core Laboratories to Neutral From Underperform	MT
07/10/22	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $17 From $24	MT
26/09/22	Morgan Stanley Downgrades Core Laboratories to Underweight From Equal Weight, Keeps $20 Price Target	MT
02/08/22	Cowen Lowers Core Laboratories Price Target to $17 From $22, Maintains Market Perform Rating	MT
01/08/22	Morgan Stanley Lowers Core Laboratories' Price Target to $20 From $22, Maintains Equalweight Rating	MT
15/07/22	BofA Securities Adjusts Core Laboratories Price Target to $17 From $25, Maintains Underperform Rating	MT
13/07/22	Morgan Stanley Adjusts Core Laboratories' Price Target to $22 from $32, Keeps Equalweight Rating	MT
13/07/22	Morgan Stanley Adjusts Core Laboratories N.V 's Price Target to $22 From $32, Keeps Equalweight Rating	MT
02/05/22	Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating	MT
18/04/22	Piper Sandler Downgrades Core Laboratories to Underweight From Neutral	MT
11/04/22	Morgan Stanley Adjusts Core Laboratories' Price Target to $35 from $30, Keeps Equalweight Rating	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
CORE LABORATORIES INC.	-			+24.11%
SGS SA				+10.52%
UL SOLUTIONS INC.				+12.4%
CENTRE TESTING INTERNATIONAL GROUP CO. LTD.				+37.05%
CHINA AUTOMOTIVE ENGINEERING RESEARCH INSTITUTE CO., LTD.		-	-	+49.25%
TIC SOLUTIONS, INC.				+39.31%
EMTEK (SHENZHEN) CO., LTD.		-	-	-
GRG METROLOGY & TEST GROUP CO., LTD.				+56.06%
Average				+32.67%
Weighted average by Cap.				+17.20%